U.S. markets closed

Triple-S Management Corporation (GTS)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
24.53+0.50 (+2.08%)
At close: 4:00PM EST
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
Commodity Channel Index

Commodity Channel Index

Previous Close24.03
Open23.73
Bid24.41 x 800
Ask24.48 x 900
Day's Range23.66 - 24.53
52 Week Range9.13 - 24.79
Volume76,220
Avg. Volume93,213
Market Cap574.743M
Beta (5Y Monthly)0.74
PE Ratio (TTM)10.61
EPS (TTM)2.31
Earnings DateFeb 25, 2021 - Mar 01, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Near Fair Value
1% Est. Return
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
View more
  • Benzinga

    5 Value Stocks In The Healthcare Sector

    What Defines a Value Stock? A value stock traditionally has a lower price when compared to stock prices of companies in the same industry. This indicates that the company may be undervalued, as investors are not expressing as much interest in such companies. The most commonly used way to check for value is with the price-to-earnings multiple, or P/E. A low P/E multiple is a good indication that the stock is undervalued.Benzinga Insights has compiled a list of value stocks in the healthcare sector that may be worth watching: 1. RAPT Therapeutics (NASDAQ:RAPT) - P/E: 0.75 2. Satsuma Pharmaceuticals (NASDAQ:STSA) - P/E: 2.65 3. Triple-S Management (NYSE:GTS) - P/E: 9.26 4. Greenlane Holdings (NASDAQ:GNLN) - P/E: 6.15 5. Jaguar Health (NASDAQ:JAGX) - P/E: 0.21Most recently, RAPT Therapeutics reported earnings per share at -0.6, whereas in Q2 earnings per share sat at -0.51. RAPT Therapeutics does not have a dividend yield, which investors should be aware of when considering holding onto such a stock.Most recently, Satsuma Pharmaceuticals reported earnings per share at -0.69, whereas in Q2 earnings per share sat at -0.65. Satsuma Pharmaceuticals does not have a dividend yield, which investors should be aware of when considering holding onto such a stock.Most recently, Triple-S Management reported earnings per share at 0.61, whereas in Q2 earnings per share sat at 1.76. Triple-S Management does not have a dividend yield, which investors should be aware of when considering holding onto such a stock.Greenlane Holdings's earnings per share for Q3 sits at -0.35, whereas in Q2, they were at -0.46. Greenlane Holdings does not have a dividend yield, which investors should be aware of when considering holding onto such a stock.Jaguar Health has reported Q3 earnings per share at -0.21, which has increased by 52.27% compared to Q2, which was -0.44. Jaguar Health does not have a dividend yield, which investors should be aware of when considering holding onto such a stock.The Significance: A value stock may need some time to rebound from its undervalued position. The risk of investing in a value stock is that this emergence may never materialize.See more from Benzinga * Click here for options trades from Benzinga * Overview Of Value Stocks In The Real Estate Sector * Stocks That Hit 52-Week Lows On Monday(C) 2020 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

  • Is GTS A Good Stock To Buy Now?
    Insider Monkey

    Is GTS A Good Stock To Buy Now?

    The financial regulations require hedge funds and wealthy investors that exceeded the $100 million equity holdings threshold to file a report that shows their positions at the end of every quarter. Even though it isn’t the intention, these filings to a certain extent level the playing field for ordinary investors. The latest round of 13F […]

  • Triple-S Management Corporation Announces Chief Financial Officer Juan José Román-Jiménez to Retire
    PR Newswire

    Triple-S Management Corporation Announces Chief Financial Officer Juan José Román-Jiménez to Retire

    Triple-S Management Corporation (NYSE: GTS), a leading health services company in Puerto Rico, today announced its Executive Vice President and Chief Financial Officer Juan José Román-Jiménez will retire at the conclusion of a planned transition, capping a three-decade career as a finance executive that included serving as CFO for two public companies. Mr. Román-Jiménez will remain in his role until his successor is chosen and will help ensure a smooth and orderly transition. Triple-S Management has engaged an executive search firm to identify suitable candidates for the CFO role and aims to complete the process by the close of the second quarter of 2021.